AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $290,000 | -45.7% | 7,000 | -50.5% | 0.01% | -41.7% |
Q4 2021 | $534,000 | -6.2% | 14,139 | -18.1% | 0.01% | 0.0% |
Q3 2021 | $569,000 | -35.2% | 17,266 | +32.7% | 0.01% | -36.8% |
Q2 2021 | $878,000 | +23.5% | 13,015 | +3.7% | 0.02% | +18.8% |
Q1 2021 | $711,000 | -33.2% | 12,550 | -3.9% | 0.02% | -23.8% |
Q4 2020 | $1,064,000 | +49.2% | 13,063 | +30.6% | 0.02% | +10.5% |
Q3 2020 | $713,000 | +73.5% | 10,000 | +100.0% | 0.02% | +58.3% |
Q2 2020 | $411,000 | – | 5,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |